nach oben

Erschienen in:

01.12.2012 | Diagnostic Neuroradiology

Is radiological evaluation as good as computer-based volumetry to assess hippocampal atrophy in Alzheimer’s disease?

verfasst von: Claire Boutet, Marie Chupin, Olivier Colliot, Marie Sarazin, Gurkan Mutlu, Aurélie Drier, Audrey Pellot, Didier Dormont, Stéphane Lehéricy, And the Alzheimer’s Disease Neuroimaging Initiative

Erschienen in: Neuroradiology | Ausgabe 12/2012

Einloggen, um Zugang zu erhalten

Abstract

Introduction

Hippocampus volumetry is a useful surrogate marker for the diagnosis of Alzheimer’s disease (AD). Our purpose was to compare visual assessment of medial temporal lobe atrophy made by radiologists with automatic hippocampal volume and to compare their performances for the classification of AD, mild cognitive impairment (MCI) and cognitively normal (CN).

Methods

We studied 30 CN, 30 MCI and 30 AD subjects. Six radiologists with two levels of expertise performed two readings of medial temporal lobe atrophy. Medial temporal lobe atrophy was evaluated on coronal three-dimensional T1-weighted images using Scheltens scale and compared with hippocampal volume obtained using a fully automatic segmentation method (Spearman’s rank coefficient).

Results

Visual assessment of medial temporal lobe atrophy was correlated with hippocampal volume (p < 0.01). Classification performances between MCI converter and CN was better using volumetry than visual assessment of non-expert readers whereas classification of AD and CN did not differ between visual assessment and volumetry except for the first reading of one non-expert (p = 0.03).

Conclusions

Visual assessment of medial temporal lobe atrophy by radiologists was well correlated with hippocampal volume. Radiological assessment is as good as computer-based volumetry for the classification of AD, MCI non-converter and CN and less good for the classification of MCI converter versus CN. Use of Scheltens scale for assessing hippocampal atrophy in AD seems thus justified in clinical routine.

McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease. Neurology 34(7):939–944PubMedCrossRef

Dubois B, Feldman HH, Jacova C, Dekosky ST, Barberger-Gateau P, Cummings J, Delacourte A, Galasko D, Gauthier S, Jicha G, Meguro K, O’brien J, Pasquier F, Robert P, Rossor M, Salloway S, Stern Y, Visser PJ, Scheltens P (2007) Research criteria for the diagnosis of Alzheimer’s disease: revising the NINCDS-ADRDA criteria. Lancet Neurol 6(8):734–746PubMedCrossRef

Jack CR, Albert MS, Knopman DS, McKhann GM, Sperling RA, Carrillo MC, Thies B, Phelps CH (2011) Introduction to the recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement 7(3):257–262PubMedCrossRef

Bottino CM, Castro CC, Gomes RL, Buchpiguel CA, Marchetti RL, Neto MR (2002) Volumetric MRI measurements can differentiate Alzheimer’s disease, mild cognitive impairment, and normal aging. Int Psychogeriatr 14(1):59–72PubMedCrossRef

Jack CR, Petersen RC, O’Brien PC, Tangalos EG (1992) MR-based hippocampal volumetry in the diagnosis of Alzheimer’s disease. Neurology 42(1):183–188PubMedCrossRef

Lehéricy S, Baulac M, Chiras J, Piérot L, Martin N, Pillon B, Deweer B, Dubois B, Marsault C (1994) Amygdalohippocampal MR volume measurements in the early stages of Alzheimer disease. AJNR Am J Neuroradiol 15(5):929–937PubMed

Colliot O, Chételat G, Chupin M, Desgranges B, Magnin B, Benali H, Dubois B, Garnero L, Eustache F, Lehéricy S (2008) Discrimination between Alzheimer disease, mild cognitive impairment, and normal aging by using automated segmentation of the hippocampus. Radiology 248(1):194–201PubMedCrossRef

Wahlund LO, Julin P, Johansson SE, Scheltens P (2000) Visual rating and volumetry of the medial temporal lobe on magnetic resonance imaging in dementia: a comparative study. J Neurol Neurosurg Psychiatry 69(5):630–635PubMedCrossRef

Scheltens P, Leys D, Barkhof F, Huglo D, Weinstein HC, Vermersch P, Kuiper M, Steinling M, Wolters EC, Valk J (1992) Atrophy of medial temporal lobes on MRI in “probable” Alzheimer’s disease and normal ageing: diagnostic value and neuropsychological correlates. J Neurol Neurosurg Psychiatry 55(10):967–972PubMedCrossRef

10.

Scheltens P, Launer LJ, Barkhof F, Weinstein HC, van Gool WA (1995) Visual assessment of medial temporal lobe atrophy on magnetic resonance imaging: interobserver reliability. J Neurol 242(9):557–560PubMedCrossRef

11.

Teipel SJ, Born C, Ewers M, Bokde AL, Reiser MF, Möller HJ, Hampel H (2007) Multivariate deformation-based analysis of brain atrophy to predict Alzheimer’s disease in mild cognitive impairment. NeuroImage 38(1):13–24PubMedCrossRef

12.

Vemuri P, Gunter JL, Senjem ML, Whitwell JL, Kantarci K, Knopman DS, Boeve BF, Petersen RC, Jack CR (2008) Alzheimer’s disease diagnosis in individual subjects using structural MR images: validation studies. NeuroImage 39(3):1186–1197PubMedCrossRef

13.

Cuingnet R, Gerardin E, Tessieras J, Auzias G, Lehéricy S, Habert MO, Chupin M, Benali H, Colliot O, Initiative TAsDN (2010) Automatic classification of patients with Alzheimer’s disease from structural MRI: A comparison of ten methods using the ADNI database. NeuroImage 56:766–781PubMedCrossRef

14.

Matsuda H, Mizumura S, Nemoto K, Yamashita F, Imabayashi E, Sato N, Asada T (2012) Automatic voxel-based morphometry of structural MRI by SPM8 plus diffeomorphic anatomic registration through exponentiated lie algebra improves the diagnosis of probable Alzheimer disease. AJNR Am J Neuroradiol (in press)

15.

Driscoll I, Davatzikos C, An Y, Wu X, Shen D, Kraut M, Resnick SM (2009) Longitudinal pattern of regional brain volume change differentiates normal aging from MCI. Neurology 72(22):1906–1913PubMedCrossRef

16.

Karas GB, Burton EJ, Rombouts SA, van Schijndel RA, O’Brien JT, Scheltens P, McKeith IG, Williams D, Ballard C, Barkhof F (2003) A comprehensive study of gray matter loss in patients with Alzheimer’s disease using optimized voxel-based morphometry. NeuroImage 18(4):895–907PubMedCrossRef

17.

Klöppel S, Stonnington CM, Barnes J, Chen F, Chu C, Good CD, Mader I, Mitchell LA, Patel AC, Roberts CC, Fox NC, Jack CR, Ashburner J, Frackowiak RS (2008) Accuracy of dementia diagnosis: a direct comparison between radiologists and a computerized method. Brain 131(Pt 11):2969–2974PubMedCrossRef

18.

Folstein MF, Folstein SE, McHugh PR (1975) Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12(3):189–198PubMedCrossRef

19.

Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL (1982) A new clinical scale for the staging of dementia. Br J Psychiatry 140:566–572PubMedCrossRef

20.

Jack CR, Bernstein MA, Fox NC, Thompson P, Alexander G, Harvey D, Borowski B, Britson PJ, Whitwell LJ, Ward C, Dale AM, Felmlee JP, Gunter JL, Hill DL, Killiany R, Schuff N, Fox-Bosetti S, Lin C, Studholme C, DeCarli CS, Krueger G, Ward HA, Metzger GJ, Scott KT, Mallozzi R, Blezek D, Levy J, Debbins JP, Fleisher AS, Albert M, Green R, Bartzokis G, Glover G, Mugler J, Weiner MW (2008) The Alzheimer’s Disease Neuroimaging Initiative (ADNI): MRI methods. J Magn Reson Imaging 27(4):685–691PubMedCrossRef

21.

Jovicich J, Czanner S, Greve D, Haley E, van der Kouwe A, Gollub R, Kennedy D, Schmitt F, Brown G, Macfall J, Fischl B, Dale A (2006) Reliability in multi-site structural MRI studies: effects of gradient non-linearity correction on phantom and human data. NeuroImage 30(2):436–443PubMedCrossRef

22.

Narayana PA, Brey WW, Kulkarni MV, Sievenpiper CL (1988) Compensation for surface coil sensitivity variation in magnetic resonance imaging. Magn Reson Imaging 6(3):271–274PubMedCrossRef

23.

Chupin M, Mukuna-Bantumbakulu AR, Hasboun D, Bardinet E, Baillet S, Kinkingnéhun S, Lemieux L, Dubois B, Garnero L (2007) Anatomically constrained region deformation for the automated segmentation of the hippocampus and the amygdala: method and validation on controls and patients with Alzheimer’s disease. NeuroImage 34(3):996–1019PubMedCrossRef

24.

Chupin M, Hammers A, Liu RS, Colliot O, Burdett J, Bardinet E, Duncan JS, Garnero L, Lemieux L (2009) Automatic segmentation of the hippocampus and the amygdala driven by hybrid constraints: method and validation. NeuroImage 46(3):749–761PubMedCrossRef

25.

Chupin M, Gérardin E, Cuingnet R, Boutet C, Lemieux L, Lehéricy S, Benali H, Garnero L, Colliot O, AsDN I (2009) Fully automatic hippocampus segmentation and classification in Alzheimer’s disease and mild cognitive impairment applied on data from ADNI. Hippocampus 19(6):579–587PubMedCrossRef

26.

Rorden C, Brett M (2000) Stereotaxic display of brain lesions. Behav Neurol 12(4):191–200PubMed

27.

Bresciani L, Rossi R, Testa C, Geroldi C, Galluzzi S, Laakso MP, Beltramello A, Soininen H, Frisoni GB (2005) Visual assessment of medial temporal atrophy on MR films in Alzheimer’s disease: comparison with volumetry. Aging Clin Exp Res 17(1):8–13PubMed

28.

Wahlund LO, Julin P, Lindqvist J, Scheltens P (1999) Visual assessment of medical temporal lobe atrophy in demented and healthy control subjects: correlation with volumetry. Psychiatry Res 90(3):193–199PubMedCrossRef

29.

Ridha BH, Barnes J, van de Pol LA, Schott JM, Boyes RG, Siddique MM, Rossor MN, Scheltens P, Fox NC (2007) Application of automated medial temporal lobe atrophy scale to Alzheimer disease. Arch Neurol 64(6):849–854PubMedCrossRef

30.

Visser PJ, Verhey FR, Hofman PA, Scheltens P, Jolles J (2002) Medial temporal lobe atrophy predicts Alzheimer’s disease in patients with minor cognitive impairment. J Neurol Neurosurg Psychiatry 72(4):491–497PubMed

31.

de Leon MJ, Convit A, George AE, Golomb J, de Santi S, Tarshish C, Rusinek H, Bobinski M, Ince C, Miller D, Wisniewski H (1996) In vivo structural studies of the hippocampus in normal aging and in incipient Alzheimer’s disease. Ann N Y Acad Sci 777:1–13PubMedCrossRef

32.

Frisoni GB, Laakso MP, Beltramello A, Geroldi C, Bianchetti A, Soininen H, Trabucchi M (1999) Hippocampal and entorhinal cortex atrophy in frontotemporal dementia and Alzheimer’s disease. Neurology 52(1):91–100PubMedCrossRef

33.

Pennanen C, Kivipelto M, Tuomainen S, Hartikainen P, Hänninen T, Laakso MP, Hallikainen M, Vanhanen M, Nissinen A, Helkala EL, Vainio P, Vanninen R, Partanen K, Soininen H (2004) Hippocampus and entorhinal cortex in mild cognitive impairment and early AD. Neurobiol Aging 25(3):303–310PubMedCrossRef

34.

Westman E, Cavallin L, Muehlboeck JS, Zhang Y, Mecocci P, Vellas B, Tsolaki M, Kłoszewska I, Soininen H, Spenger C, Lovestone S, Simmons A, Wahlund LO, consortium A (2011) Sensitivity and specificity of medial temporal lobe visual ratings and multivariate regional MRI classification in Alzheimer’s disease. PLoS One 6(7):e22506PubMedCrossRef

35.

Duara R, Loewenstein DA, Potter E, Appel J, Greig MT, Urs R, Shen Q, Raj A, Small B, Barker W, Schofield E, Wu Y, Potter H (2008) Medial temporal lobe atrophy on MRI scans and the diagnosis of Alzheimer disease. Neurology 71(24):1986–1992PubMedCrossRef

36.

DeCarli C, Frisoni GB, Clark CM, Harvey D, Grundman M, Petersen RC, Thal LJ, Jin S, Jack CR, Scheltens P, Group AsDCS (2007) Qualitative estimates of medial temporal atrophy as a predictor of progression from mild cognitive impairment to dementia. Arch Neurol 64(1):108–115PubMedCrossRef

37.

Knoops AJ, van der Graaf Y, Appelman AP, Gerritsen L, Mali WP, Geerlings MI (2009) Visual rating of the hippocampus in non-demented elders: does it measure hippocampal atrophy or other indices of brain atrophy? The SMART-MR study. Hippocampus 19(11):1115–1122PubMedCrossRef

Titel: Is radiological evaluation as good as computer-based volumetry to assess hippocampal atrophy in Alzheimer’s disease?
verfasst von: Claire Boutet
Marie Chupin
Olivier Colliot
Marie Sarazin
Gurkan Mutlu
Aurélie Drier
Audrey Pellot
Didier Dormont
Stéphane Lehéricy
And the Alzheimer’s Disease Neuroimaging Initiative
Publikationsdatum: 01.12.2012
Verlag: Springer-Verlag
Erschienen in: Neuroradiology / Ausgabe 12/2012
Print ISSN: 0028-3940
Elektronische ISSN: 1432-1920
DOI: https://doi.org/10.1007/s00234-012-1058-0

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

23.04.2024 | Demenz | Nachrichten

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Is radiological evaluation as good as computer-based volumetry to assess hippocampal atrophy in Alzheimer’s disease?

Abstract

Introduction

Methods

Results

Conclusions

Leitlinien kompakt für die Neurologie

Neu im Fachgebiet Neurologie

Demenzkranke durch Antipsychotika vielfach gefährdet

Parkinson-Therapie im Wandel – aktuelle Leitlinie im Fokus

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

Hustenstiller lindert Agitation bei Alzheimer

Update Neurologie

Springer Medizin

Abstract

Introduction

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 12/2012

Imaging findings in seven cases of congenital infantile myofibromatosis with cerebral, spinal, or head and neck involvement

Factors affecting long-term restenosis after carotid stenting for carotid atherosclerotic disease

Accuracy for predicting adhesion between meningioma and the brain by using brain surface motion imaging: comparison between single and double acquisition methods

Future trials of endovascular mechanical recanalisation therapy in acute ischemic stroke patients: a position paper endorsed by ESMINT and ESNR

Spinal cord stimulation modulates cerebral function: an fMRI study

Future trials of endovascular mechanical recanalisation therapy in acute ischemic stroke patients - A position paper endorsed by ESMINT and ESNR

Leitlinien kompakt für die Neurologie

Neu im Fachgebiet Neurologie

Demenzkranke durch Antipsychotika vielfach gefährdet

Parkinson-Therapie im Wandel – aktuelle Leitlinie im Fokus

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

Hustenstiller lindert Agitation bei Alzheimer

Update Neurologie